Literature DB >> 18096416

The molecular heterogeneity of beta-thalassemia in Greece.

Marina Boussiou1, Photini Karababa, Klio Sinopoulou, Panagiotis Tsaftaridis, Eleni Plata, Aphrodite Loutradi-Anagnostou.   

Abstract

Beta-thalassemia is the most predominant genetic defect in Greece. In this study, we investigated the heterogeneity and the frequency of beta-thalassemia mutations among 3796 heterozygotes detected in the course of DNA based diagnoses. The diagnostic strategy included Denaturing Gradient Gel Electrophoresis (DGGE), Allele Specific Oligonucleotide Hybridization (ASO), GAP PCR, Restriction Enzyme (RE) analysis and direct sequencing and led to 100% identification of the underlying molecular lesion. Six out of 33 different beta-globin defects identified accounted for more than 91.4% of the total beta-thalassemia chromosomes in Greece. The beta-globin gene mutations cd29 C-->T, IVS-I-2 T-->C, IVS-I-5 G-->T, cd37 G-->A and poly A Kurdish AATAAA-->AATAAG are for the first time reported in Greece, whereas cd7 GAG-->TAG is a new beta(0)-thalassemia mutation detected in an adult man from Albania residing in Greece. Three DNA single nucleotide polymorphisms (IVS-I-85 T-->C, IVS-I-91 C-->T and IVS-I-108 T-->C) were also revealed; among these, IVS-I-85 T-->C and IVS-I-91 C-->T are new and described for the first time worldwide.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18096416     DOI: 10.1016/j.bcmd.2007.11.003

Source DB:  PubMed          Journal:  Blood Cells Mol Dis        ISSN: 1079-9796            Impact factor:   3.039


  6 in total

1.  A search for β thalassemia mutations in 4000 year old ancient DNAs of Minoan Cretans.

Authors:  Jeffery R Hughey; Meijun Du; Qiliang Li; Manolis Michalodimitrakis; George Stamatoyannopoulos
Journal:  Blood Cells Mol Dis       Date:  2011-10-14       Impact factor: 3.039

2.  Innate Variability in Physiological and Omics Aspects of the Beta Thalassemia Trait-Specific Donor Variation Effects.

Authors:  Alkmini T Anastasiadi; Vassilis L Tzounakas; Monika Dzieciatkowska; Vasiliki-Zoi Arvaniti; Effie G Papageorgiou; Issidora S Papassideri; Konstantinos Stamoulis; Angelo D'Alessandro; Anastasios G Kriebardis; Marianna H Antonelou
Journal:  Front Physiol       Date:  2022-06-08       Impact factor: 4.755

3.  Development of a High-Resolution Melting Approach for Scanning Beta Globin Gene Point Mutations in the Greek and Other Mediterranean Populations.

Authors:  Christos Chassanidis; Effrossyni Boutou; Ersi Voskaridou; Angeliki Balassopoulou
Journal:  PLoS One       Date:  2016-06-28       Impact factor: 3.240

Review 4.  Novel genetic therapeutic approaches for modulating the severity of β-thalassemia (Review).

Authors:  Fareeha Amjad; Tamseel Fatima; Tuba Fayyaz; Muhammad Aslam Khan; Muhammad Imran Qadeer
Journal:  Biomed Rep       Date:  2020-09-02

5.  Heterozygosity of the Complex Corfu δ0β+ Thalassemic Allele (HBD Deletion and HBB:c.92+5G>A) Revisited.

Authors:  Christos Kattamis; Myrto Skafida; Polyxeni Delaporta; Christina Vrettou; Joanne Traeger-Synodinos; Christalena Sofocleous; Antonis Kattamis
Journal:  Biology (Basel)       Date:  2022-03-11

6.  Insights into the genetic architecture of haematological traits from deep phenotyping and whole-genome sequencing for two Mediterranean isolated populations.

Authors:  Karoline Kuchenbaecker; Arthur Gilly; Daniel Suveges; Lorraine Southam; Olga Giannakopoulou; Britt Kilian; Emmanouil Tsafantakis; Maria Karaleftheri; Aliki-Eleni Farmaki; Deepti Gurdasani; Kousik Kundu; Manjinder S Sandhu; John Danesh; Adam Butterworth; Inês Barroso; George Dedoussis; Eleftheria Zeggini
Journal:  Sci Rep       Date:  2022-01-21       Impact factor: 4.996

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.